JPRN-UMIN000004462已完成未知
The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD) - The study for beneficial efficacy of ezetimibe in patients with hyper LDL-cholesterolemia with diabetes and NAFLD
Geriatric Medicine, Osaka University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) the subjects currently receiving ezetimibe 2) the subjects infected with hepatitis B or C virus 3) the subjects with more than 500mg/dl of triglyceride 4) the subjects with familial hyperlipidemia, secondary hyperlipidemia and drug induced-hyperlipidemia 5) the subjects drinking alcohol more than 21g per day frequently 6) the subjects receiving pioglitazone 7) the subjects recommended the other medication 8) the subjects with hyperlipidemia induced by: hypothyroidism, obstructive biliary tract disease, pancreatitis, cushing syndrome, lupus erythematosus, malignant lymphoma, myeloma. 9) the subjects with poor controlled diabetes (HbA1c > 9.0%) 10) the subjects having a history of a previous drug allergy 11) the subjects during pregnancy or lactation 12) the subjects found offensive by attending physicians for this research
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaEUCTR2004-003807-19-ESMerck & Co Inc.600
进行中（未招募）
不适用
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762EUCTR2004-003807-19-ATMerck, Sharp & Dohme600
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMedDRA version: 7.0 Level: LLT Classification code 10027762Mixed hyperlipidemiaEUCTR2004-003807-19-GBMerck Sharp & Dohme Ltd600
进行中（未招募）
不适用
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMedDRA version: 7.0Level: LLTClassification code 10027762Mixed hyperlipidemiaEUCTR2004-003807-19-HUMerck & Co., Inc.600
尚未招募
2 期
Exploratory survey of the safety and efficacy of endoscopic radiofrequency ablation for malignant biliary strictureMalignant biliary strictureJPRN-UMIN000031601Graduate School of Medicine, Chiba University10